Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

LEF-553: a potent mu-opioid receptor agonist with peripheral analgesic effects

Nov. 10, 1998

NK1 antagonist L-732138 exhibits activity indicating efficacy in neuropathic pain

Nov. 10, 1998

Novel sodium channel blocker from Roche evaluated in vitro for neuroprotective efficacy

Nov. 10, 1998

Reversible mixed MAO-A/MAO-B inhibitor discovered at Synthelabo is presented this week

Nov. 10, 1998

RPR-118723: a novel anticonvulsant and potent glycine-site NMDA receptor antagonist

Nov. 10, 1998

Pfizer presents preclinical profile of potent, full 5-HT1D receptor antagonist

Nov. 10, 1998

Pharmacia & Upjohn patents new agents for CNS and neurodegenerative disorders

Nov. 10, 1998

Noncytotoxic thiocolchicine derivatives useful as muscle relaxants

Nov. 10, 1998

Compounds acting on metabotropic glutamate receptors disclosed by Lilly

Nov. 10, 1998

Novel compounds from ADIR acting on the dopaminergic system

Nov. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.